NEW YORK (GenomeWeb News) – Qiagen will repurchase the euro equivalent of up to $10 million of its shares starting Oct. 1 as part of the company's first share repurchase program, it said late on Friday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.
Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.
According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.
National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.